How to Save $1 Billion on Pharmaceuticals by 2020
By Scott MacDougallSanofi is taking an aggressive approach to its $1.4 billion acquisition of Vivo Pharmaceuticals.The $7.2 billion deal is expected to close by the end of this year.The acquisition of a small but significant company in Sanofi’s portfolio of pharmaceuticals is part of a broader plan to expand its portfolio of drugs in the…